[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.49.6. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 4, 1983

Posttransfusion Hepatitis Type A

Author Affiliations

From the Departments of Virology and Epidemiology (Drs Hollinger, Khan, Oefinger, Dreesman, and Melnick), Medicine (Dr Schmulen), and Pathology (Dr Yawn), Baylor College of Medicine, Houston.

JAMA. 1983;250(17):2313-2317. doi:10.1001/jama.1983.03340170039025
Abstract

Hepatitis A virus (HAV) transmission through blood is a rare but potential cause of posttransfusion hepatitis. We can now document such a case supported by laboratory evidence of HAV in the donor blood. A 10-year-old girl manifested icteric hepatitis A 31 days after receiving a single unit of packed RBCs from a donor who subsequently experienced hepatitis A and died in hepatic failure. Hepatitis A virus antigen was detected in the donor's hepatocytes and in plasma obtained from the original donor unit. The density in cesium chloride of the HAV antigenic activity from the liver and plasma ranged from 1.33 to 1.37 g/cu cm, which is similar to that reported for infectious HAV particles. The implicated donor plasma had normal aminotransferase levels and was negative for antibody to HAV. Inoculation of this plasma into a chimpanzee resulted in the development of hepatitis A 23 days later based on the appearance of fecal HAV antigen, hepatitis, and IgM anti-HAV seroconversion. These data clearly document the presence of HAV in the donor sample that produced posttransfusion hepatitis A.

(JAMA 1983;250:2313-2317)

×